Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Corvus Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +1 vs. Q2 2022
- Shares held
- 22.1M
- −3.51M (−13.7%) vs. Q2 2022
- Total value
- $18.1M
- −$7.27M (−28.7%) vs. Q2 2022
- New holders
- 6
- 10 more added
- Sold out
- 5
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $0 | 0.00% | −9,670−100.0% | Reduced |
| Citigroup Inc | 526 | $0 | 0.00% | −158−23.1% | Reduced |
| Bank of America Corp | 254 | $0 | 0.00% | −209−45.1% | Reduced |
| Wells Fargo & Company | 229 | $0 | 0.00% | +11+5.0% | Added |
| Parallel Advisors, LLC | 20 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 272 | $0 | 0.00% | +272 | New |
| China Universal Asset Management Co., Ltd. | 436 | $0 | 0.00% | +436 | New |
| BNP Paribas Arbitrage, SA | 99 | $81 | 0.00% | −1,125−91.9% | Reduced |
| TCI Wealth Advisors, Inc. | 800 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 1,750 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,786 | $2.00K | 0.00% | +818+41.6% | Added |
| Whittier Trust Co of Nevada Inc | 4,200 | $3.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 7,049 | $6.00K | 0.00% | −21,748−75.5% | Reduced |
| Wolverine Trading, LLC | 10,688 | $8.00K | 0.00% | +10,688 | New |
| Leonteq Securities AG | 10,000 | $8.19K | 0.00% | +2,000+25.0% | Added |
| Mercer Global Advisors Inc | 10,550 | $9.00K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 10,500 | $9.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,668 | $10.0K | 0.00% | +2,335+25.0% | Added |
| Susquehanna Fundamental Investments, LLC | 13,790 | $11.0K | 0.00% | +13,790 | New |
| Simplex Trading, LLC | 16,050 | $13.0K | 0.00% | −9,548−37.3% | Reduced |
| Goldman Sachs Group Inc | 17,261 | $14.0K | 0.00% | −22,589−56.7% | Reduced |
| Jane Street Group, LLC | 20,775 | $17.0K | 0.00% | +20,775 | New |
| UBS Group AG | 22,656 | $18.0K | 0.00% | +85+0.4% | Added |
| LMR Partners LLP | 30,000 | $25.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 37,051 | $30.0K | 0.00% | −195,766−84.1% | Reduced |
| Morgan Stanley | 39,317 | $32.0K | 0.00% | −10,031−20.3% | Reduced |
| Bailard, Inc. | 39,998 | $33.0K | 0.00% | +39,998 | New |
| Hikari Power Ltd | 49,959 | $41.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 52,226 | $43.0K | 0.00% | 00.0% | Unchanged |
| Jackson Square Capital, LLC | 63,773 | $52.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 112,603 | $92.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 142,160 | $115.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 159,300 | $130.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 298,460 | $244.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 429,708 | $352.0K | 0.00% | +68,674+19.0% | Added |
| Two Sigma Advisers, LP | 480,100 | $393.0K | 0.00% | +106,700+28.6% | Added |
| Artal Group S.A. | 500,000 | $409.0K | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 502,942 | $411.0K | 0.00% | −2,624−0.5% | Reduced |
| Telemetry Investments, L.L.C. | 522,009 | $427.0K | 0.70% | +61,906+13.5% | Added |
| Renaissance Technologies LLC | 975,519 | $798.0K | 0.00% | +12,587+1.3% | Added |
| Vanguard Group Inc | 1,259,906 | $1.03M | 0.00% | −7,846−0.6% | Reduced |
| BVF Inc | 1,370,947 | $1.12M | 0.05% | 00.0% | Unchanged |
| Millennium Management LLC | 2,265,312 | $1.85M | 0.00% | −422,631−15.7% | Reduced |
| CHI Advisors LLC | 2,384,402 | $1.95M | 0.52% | +170,218+7.7% | Added |
| Adams Street Partners LLC | 3,275,616 | $2.68M | 0.73% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 6,943,654 | $5.68M | 0.11% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −3,301,709−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,355−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −1,984−100.0% | Sold out |
| Optimum Investment Advisors | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |